Whooping cough vaccine safety checked in 2,700 thai moms and babies
NCT ID NCT06888076
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviews medical records of about 2,700 pregnant women in Thailand who received the Pertagen® whooping cough vaccine and their babies. Researchers want to see if the vaccine is linked to any delivery complications or health issues in newborns. The goal is to confirm the vaccine is safe for both mother and child.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERTUSSIS (WHOOPING COUGH) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Medicine Siriraj Hospital Mahidol University
Bangkok, Bangkok, 10700, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a routine pregnancy vaccine influence breastfeeding and baby health? a massive study digs into the data.
- Can a booster shot stop whooping cough bacteria in its tracks?
- New vaccine trial aims to shield teens and adults from whooping cough
- Thousands monitored: is the whooping cough vaccine safe in real life?
- New Low-Dose tdap vaccine trial aims to boost protection with fewer side effects
- Whooping cough vaccine safety under the microscope in thailand